The factors associated with the quality of life among postmenopausal women.
Dietary supplements
Health
Postmenopause
Quality of life
Smoking
Women
Journal
BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690
Informations de publication
Date de publication:
18 05 2021
18 05 2021
Historique:
received:
24
01
2021
accepted:
13
05
2021
entrez:
19
5
2021
pubmed:
20
5
2021
medline:
1
6
2021
Statut:
epublish
Résumé
The present work aimed at determining the prevalence of menopausal symptoms and factors associated with the Quality of life among postmenopausal women. This cross-sectional work was carried out on 270 postmenopausal females referring to health centers of Hamadan city chosen by stratified random sampling. A questionnaire of the Menopausal Quality of Life Questionnaire (MENQOL) was used as the data collection method. Although, the Mann-Whitney test and the Kruskal-Wallis tests were used to compare MENQOL item scores. The significance level of statistical tests was regarded as less than 0.05. The mean MENQOL Score in menopausal was 2.45 ± 1.04. Also, vasomotor symptoms had the highest score, and sexual symptoms had the lowest score rather than other dimensions. There was a significant association between the total menopausal quality of life score and job, economy status, smoking, exercise, supplemental Omega-3 s intake, and Postmenopausal stage (p < 0.01). As smokers, women had increasing levels of bother experienced from the MENQOL symptom than non-smokers (mean = 3.67 ± 0.85 vs. 2.36 ± 0.99; p < 0.001). While the MENQOL scores for menopausal females who exercised more often (mean = 1.56 ± 0.7) had lower than those who exercised less than 3 times per week (mean = 3.27 ± 0.9; p < 0.001). However the lowest score was menopausal females who had taking supplemental Omega-3 s than those who hadn't taken it (mean = 2.15 ± 1.06 vs. 2.65 ± 0.97; p < 0.001). Though women who had postmenopausal stage less than 5 years stage (mean = 2.28 ± 0.87) had significantly lower MENQOL scores from those who had postmenopausal stage 5 or more years (mean = 2.63 ± 1.16; p < 0.001). Based on the results, vasomotor symptoms were the most dominant symptom. Therefore, it is necessary to improve physical activity levels, focusing on job status, recommend taking an omega 3 s supplement, and planning education and promotion intervention for cessation or prevention of smoking among postmenopausal women to increase the MENQOL is essential.
Identifiants
pubmed: 34006264
doi: 10.1186/s12905-021-01361-x
pii: 10.1186/s12905-021-01361-x
pmc: PMC8130393
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
208Références
J Midlife Health. 2017 Jan-Mar;8(1):21-27
pubmed: 28458476
J Egypt Public Health Assoc. 2015 Dec;90(4):166-70
pubmed: 26854898
Climacteric. 2014 Dec;17(6):705-12
pubmed: 24884351
Soc Sci Med. 1995 Nov;41(10):1403-9
pubmed: 8560308
Int J Mol Sci. 2018 Jun 23;19(7):
pubmed: 29937484
J Pak Med Assoc. 2009 Nov;59(11):752-6
pubmed: 20361673
Medicina (Kaunas). 2019 Aug 11;55(8):
pubmed: 31405242
Climacteric. 2020 Feb;23(1):9-16
pubmed: 31533486
Maturitas. 2005 Mar 14;50(3):209-21
pubmed: 15734602
Maturitas. 2012 Dec;73(4):354-60
pubmed: 23026018
J Clin Oncol. 2005 Oct 1;23(28):6931-40
pubmed: 16157934
J Menopausal Med. 2017 Apr;23(1):49-55
pubmed: 28523259
Iran Red Crescent Med J. 2011 Nov;13(11):811-7
pubmed: 22737420
Maturitas. 2011 Apr;68(4):387-90
pubmed: 21237590
J Midlife Health. 2015 Jan-Mar;6(1):21-5
pubmed: 25861204
Qual Life Res. 2010 Aug;19(6):813-9
pubmed: 20358299
Maturitas. 1996 Jul;24(3):161-75
pubmed: 8844630
Maturitas. 2000 Jan 15;34(1):17-23
pubmed: 10687878
Ann Med Health Sci Res. 2014 May;4(3):325-9
pubmed: 24971202
Maturitas. 2007 Jan 20;56(1):45-53
pubmed: 16797890
Gynecol Endocrinol. 2009 May;25(5):303-14
pubmed: 19903037